APO Research
Talk to an analyst

APO RESEARCH · REPORT

Icosapent Ethyl Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Icosapent Ethyl Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025194 pages

Choose your research edition.

Industry ResearchIcosapent Ethyl Drugs Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Icosapent Ethyl Drugs Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Icosapent Ethyl Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Icosapent Ethyl Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Icosapent Ethyl Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Icosapent Ethyl Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Icosapent Ethyl Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Icosapent Ethyl Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Icosapent Ethyl Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Icosapent Ethyl Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Icosapent Ethyl Drugs include Sichuan Gowell Pharmaceutical, Humanwell Puracap Pharmaceuticals, Qilu Pharmaceutical, Jiangsu Wangao Pharmaceutical, Chengdu Suncadia Medicine, Zydus, Woodward Pharma, Teva and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Icosapent Ethyl Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Icosapent Ethyl Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Icosapent Ethyl Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Icosapent Ethyl Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Icosapent Ethyl Drugs Segment by Company

Sichuan Gowell Pharmaceutical

Humanwell Puracap Pharmaceuticals

Qilu Pharmaceutical

Jiangsu Wangao Pharmaceutical

Chengdu Suncadia Medicine

Zydus

Woodward Pharma

Teva

Sun Pharma

Strides Pharma

PuraCap Pharmaceuticals

Mankind Pharma

Hikma

GLW Pharma

Dr. Reddy's Laboratories

Ascent Pharmaceuticals

Apotex

Amneal Pharmaceuticals

Amarin Pharmaceuticals

Icosapent Ethyl Drugs Segment by Type

Single Drug

Combination Drug

Icosapent Ethyl Drugs Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Icosapent Ethyl Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Icosapent Ethyl Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Icosapent Ethyl Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Icosapent Ethyl Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Icosapent Ethyl Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Icosapent Ethyl Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Icosapent Ethyl Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Icosapent Ethyl Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Icosapent Ethyl Drugs Industry Trends Table 2. Icosapent Ethyl Drugs Industry Drivers Table 3. Icosapent Ethyl Drugs Industry Opportunities and Challenges Table 4. Icosapent Ethyl Drugs Industry Restraints Table 5. Global Icosapent Ethyl Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Icosapent Ethyl Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Icosapent Ethyl Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Icosapent Ethyl Drugs Sales Market Share by Manufacturers Table 9. Global Icosapent Ethyl Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Icosapent Ethyl Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Icosapent Ethyl Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Icosapent Ethyl Drugs Manufacturers, Product Type & Application Table 13. Global Icosapent Ethyl Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Icosapent Ethyl Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Single Drug Table 17. Major Manufacturers of Combination Drug Table 18. Global Icosapent Ethyl Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units) Table 20. Global Icosapent Ethyl Drugs Sales by Type (2027-2032) & (K Units) Table 21. Global Icosapent Ethyl Drugs Sales Market Share by Type (2021-2026) Table 22. Global Icosapent Ethyl Drugs Sales Market Share by Type (2027-2032) Table 23. Global Icosapent Ethyl Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Icosapent Ethyl Drugs Revenue by Type (2021-2026) & (K Units) Table 25. Global Icosapent Ethyl Drugs Revenue by Type (2027-2032) & (K Units) Table 26. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021-2026) Table 27. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Retail Pharmacy Table 29. Major Manufacturers of Online Pharmacy Table 30. Major Manufacturers of Hospital Pharmacy Table 31. Global Icosapent Ethyl Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units) Table 33. Global Icosapent Ethyl Drugs Sales by Application (2027-2032) & (K Units) Table 34. Global Icosapent Ethyl Drugs Sales Market Share by Application (2021-2026) Table 35. Global Icosapent Ethyl Drugs Sales Market Share by Application (2027-2032) Table 36. Global Icosapent Ethyl Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Icosapent Ethyl Drugs Revenue by Application (2021-2026) & (K Units) Table 38. Global Icosapent Ethyl Drugs Revenue by Application (2027-2032) & (K Units) Table 39. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2021-2026) Table 40. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2027-2032) Table 41. Global Icosapent Ethyl Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Icosapent Ethyl Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global Icosapent Ethyl Drugs Sales Market Share by Region (2021-2026) Table 44. Global Icosapent Ethyl Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Icosapent Ethyl Drugs Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Icosapent Ethyl Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 48. North America Icosapent Ethyl Drugs Sales by Country (2027-2032) & (K Units) Table 49. Europe Icosapent Ethyl Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 51. Europe Icosapent Ethyl Drugs Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Icosapent Ethyl Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Icosapent Ethyl Drugs Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Icosapent Ethyl Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Icosapent Ethyl Drugs Sales by Country (2027-2032) & (K Units) Table 58. Global Icosapent Ethyl Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Icosapent Ethyl Drugs Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Icosapent Ethyl Drugs Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Icosapent Ethyl Drugs Revenue Market Share by Region (2021-2026) Table 62. Global Icosapent Ethyl Drugs Revenue Market Share by Region (2027-2032) Table 63. Sichuan Gowell Pharmaceutical Company Information Table 64. Sichuan Gowell Pharmaceutical Business Overview Table 65. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product Portfolio Table 67. Sichuan Gowell Pharmaceutical Recent Development Table 68. Humanwell Puracap Pharmaceuticals Company Information Table 69. Humanwell Puracap Pharmaceuticals Business Overview Table 70. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 72. Humanwell Puracap Pharmaceuticals Recent Development Table 73. Qilu Pharmaceutical Company Information Table 74. Qilu Pharmaceutical Business Overview Table 75. Qilu Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Qilu Pharmaceutical Icosapent Ethyl Drugs Product Portfolio Table 77. Qilu Pharmaceutical Recent Development Table 78. Jiangsu Wangao Pharmaceutical Company Information Table 79. Jiangsu Wangao Pharmaceutical Business Overview Table 80. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product Portfolio Table 82. Jiangsu Wangao Pharmaceutical Recent Development Table 83. Chengdu Suncadia Medicine Company Information Table 84. Chengdu Suncadia Medicine Business Overview Table 85. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product Portfolio Table 87. Chengdu Suncadia Medicine Recent Development Table 88. Zydus Company Information Table 89. Zydus Business Overview Table 90. Zydus Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Zydus Icosapent Ethyl Drugs Product Portfolio Table 92. Zydus Recent Development Table 93. Woodward Pharma Company Information Table 94. Woodward Pharma Business Overview Table 95. Woodward Pharma Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Woodward Pharma Icosapent Ethyl Drugs Product Portfolio Table 97. Woodward Pharma Recent Development Table 98. Teva Company Information Table 99. Teva Business Overview Table 100. Teva Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Teva Icosapent Ethyl Drugs Product Portfolio Table 102. Teva Recent Development Table 103. Sun Pharma Company Information Table 104. Sun Pharma Business Overview Table 105. Sun Pharma Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Sun Pharma Icosapent Ethyl Drugs Product Portfolio Table 107. Sun Pharma Recent Development Table 108. Strides Pharma Company Information Table 109. Strides Pharma Business Overview Table 110. Strides Pharma Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Strides Pharma Icosapent Ethyl Drugs Product Portfolio Table 112. Strides Pharma Recent Development Table 113. PuraCap Pharmaceuticals Company Information Table 114. PuraCap Pharmaceuticals Business Overview Table 115. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 117. PuraCap Pharmaceuticals Recent Development Table 118. Mankind Pharma Company Information Table 119. Mankind Pharma Business Overview Table 120. Mankind Pharma Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Mankind Pharma Icosapent Ethyl Drugs Product Portfolio Table 122. Mankind Pharma Recent Development Table 123. Hikma Company Information Table 124. Hikma Business Overview Table 125. Hikma Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Hikma Icosapent Ethyl Drugs Product Portfolio Table 127. Hikma Recent Development Table 128. GLW Pharma Company Information Table 129. GLW Pharma Business Overview Table 130. GLW Pharma Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. GLW Pharma Icosapent Ethyl Drugs Product Portfolio Table 132. GLW Pharma Recent Development Table 133. Dr. Reddy's Laboratories Company Information Table 134. Dr. Reddy's Laboratories Business Overview Table 135. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product Portfolio Table 137. Dr. Reddy's Laboratories Recent Development Table 138. Ascent Pharmaceuticals Company Information Table 139. Ascent Pharmaceuticals Business Overview Table 140. Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Ascent Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 142. Ascent Pharmaceuticals Recent Development Table 143. Apotex Company Information Table 144. Apotex Business Overview Table 145. Apotex Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Apotex Icosapent Ethyl Drugs Product Portfolio Table 147. Apotex Recent Development Table 148. Amneal Pharmaceuticals Company Information Table 149. Amneal Pharmaceuticals Business Overview Table 150. Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Amneal Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 152. Amneal Pharmaceuticals Recent Development Table 153. Amarin Pharmaceuticals Company Information Table 154. Amarin Pharmaceuticals Business Overview Table 155. Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Amarin Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 157. Amarin Pharmaceuticals Recent Development Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Icosapent Ethyl Drugs Distributors List Table 161. Icosapent Ethyl Drugs Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Icosapent Ethyl Drugs Product Image Figure 2. Global Icosapent Ethyl Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Icosapent Ethyl Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Icosapent Ethyl Drugs Sales (2021-2032) & (K Units) Figure 5. Global Icosapent Ethyl Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Icosapent Ethyl Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Single Drug Image Figure 9. Combination Drug Image Figure 10. Global Icosapent Ethyl Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Icosapent Ethyl Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Icosapent Ethyl Drugs Sales Market Share by Type (2021-2032) Figure 13. Global Icosapent Ethyl Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Icosapent Ethyl Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021-2032) Figure 16. Retail Pharmacy Image Figure 17. Online Pharmacy Image Figure 18. Hospital Pharmacy Image Figure 19. Global Icosapent Ethyl Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Icosapent Ethyl Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Icosapent Ethyl Drugs Sales Market Share by Application (2021-2032) Figure 22. Global Icosapent Ethyl Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Icosapent Ethyl Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2021-2032) Figure 25. North America Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Icosapent Ethyl Drugs Sales Market Share by Country (2021-2032) Figure 27. U.S. Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Icosapent Ethyl Drugs Sales Market Share by Country (2021-2032) Figure 32. Germany Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Icosapent Ethyl Drugs Sales Market Share by Country (2021-2032) Figure 39. China Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Icosapent Ethyl Drugs Sales Market Share by Country (2021-2032) Figure 47. Brazil Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Icosapent Ethyl Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Icosapent Ethyl Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Icosapent Ethyl Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Figure 58. North America Icosapent Ethyl Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Figure 60. Europe Icosapent Ethyl Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Icosapent Ethyl Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Icosapent Ethyl Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Icosapent Ethyl Drugs Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Icosapent Ethyl Drugs Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Single Drug
  • Combination Drug
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Sichuan Gowell Pharmaceutical
  • Humanwell Puracap Pharmaceuticals
  • Qilu Pharmaceutical
  • Jiangsu Wangao Pharmaceutical
  • Chengdu Suncadia Medicine
  • Zydus
  • Woodward Pharma
  • Teva
  • Sun Pharma
  • Strides Pharma
  • PuraCap Pharmaceuticals
  • Mankind Pharma
  • Hikma
  • GLW Pharma
  • Dr. Reddy's Laboratories
  • Ascent Pharmaceuticals
  • Apotex
  • Amneal Pharmaceuticals
  • Amarin Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Icosapent Ethyl Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Icosapent Ethyl Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Icosapent Ethyl Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Icosapent Ethyl Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Icosapent Ethyl Drugs Market Dynamics
  1. 2.1 Icosapent Ethyl Drugs Industry Trends
  2. 2.2 Icosapent Ethyl Drugs Industry Drivers
  3. 2.3 Icosapent Ethyl Drugs Industry Opportunities and Challenges
  4. 2.4 Icosapent Ethyl Drugs Industry Restraints
3 Icosapent Ethyl Drugs Market by Manufacturers
  1. 3.1 Global Icosapent Ethyl Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Icosapent Ethyl Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Icosapent Ethyl Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Icosapent Ethyl Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Icosapent Ethyl Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Icosapent Ethyl Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Icosapent Ethyl Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Icosapent Ethyl Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Icosapent Ethyl Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Icosapent Ethyl Drugs Tier 1, Tier 2, and Tier 3
4 Icosapent Ethyl Drugs Market by Type
  1. 4.1 Icosapent Ethyl Drugs Type Introduction
  2. 4.1.1 Single Drug
  3. 4.1.2 Combination Drug
  4. 4.2 Global Icosapent Ethyl Drugs Sales by Type
  5. 4.2.1 Global Icosapent Ethyl Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Icosapent Ethyl Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global Icosapent Ethyl Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global Icosapent Ethyl Drugs Revenue by Type
  9. 4.3.1 Global Icosapent Ethyl Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Icosapent Ethyl Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021-2032)
5 Icosapent Ethyl Drugs Market by Application
  1. 5.1 Icosapent Ethyl Drugs Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.2 Global Icosapent Ethyl Drugs Sales by Application
  6. 5.2.1 Global Icosapent Ethyl Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Icosapent Ethyl Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Icosapent Ethyl Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Icosapent Ethyl Drugs Revenue by Application
  10. 5.3.1 Global Icosapent Ethyl Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Icosapent Ethyl Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Icosapent Ethyl Drugs Revenue Market Share by Application (2021-2032)
6 Global Icosapent Ethyl Drugs Sales by Region
  1. 6.1 Global Icosapent Ethyl Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Icosapent Ethyl Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Icosapent Ethyl Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Icosapent Ethyl Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Icosapent Ethyl Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Icosapent Ethyl Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Icosapent Ethyl Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Icosapent Ethyl Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Icosapent Ethyl Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Icosapent Ethyl Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Icosapent Ethyl Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Icosapent Ethyl Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Icosapent Ethyl Drugs Revenue by Region
  1. 7.1 Global Icosapent Ethyl Drugs Revenue by Region
  2. 7.1.1 Global Icosapent Ethyl Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Icosapent Ethyl Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Icosapent Ethyl Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Icosapent Ethyl Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Icosapent Ethyl Drugs Revenue (2021-2032)
  8. 7.2.2 North America Icosapent Ethyl Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Icosapent Ethyl Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Icosapent Ethyl Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Icosapent Ethyl Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Icosapent Ethyl Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Icosapent Ethyl Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Icosapent Ethyl Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sichuan Gowell Pharmaceutical
  2. 8.1.1 Sichuan Gowell Pharmaceutical Company Information
  3. 8.1.2 Sichuan Gowell Pharmaceutical Business Overview
  4. 8.1.3 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
  6. 8.1.5 Sichuan Gowell Pharmaceutical Recent Developments
  7. 8.2 Humanwell Puracap Pharmaceuticals
  8. 8.2.1 Humanwell Puracap Pharmaceuticals Company Information
  9. 8.2.2 Humanwell Puracap Pharmaceuticals Business Overview
  10. 8.2.3 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  12. 8.2.5 Humanwell Puracap Pharmaceuticals Recent Developments
  13. 8.3 Qilu Pharmaceutical
  14. 8.3.1 Qilu Pharmaceutical Company Information
  15. 8.3.2 Qilu Pharmaceutical Business Overview
  16. 8.3.3 Qilu Pharmaceutical Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
  18. 8.3.5 Qilu Pharmaceutical Recent Developments
  19. 8.4 Jiangsu Wangao Pharmaceutical
  20. 8.4.1 Jiangsu Wangao Pharmaceutical Company Information
  21. 8.4.2 Jiangsu Wangao Pharmaceutical Business Overview
  22. 8.4.3 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
  24. 8.4.5 Jiangsu Wangao Pharmaceutical Recent Developments
  25. 8.5 Chengdu Suncadia Medicine
  26. 8.5.1 Chengdu Suncadia Medicine Company Information
  27. 8.5.2 Chengdu Suncadia Medicine Business Overview
  28. 8.5.3 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product Portfolio
  30. 8.5.5 Chengdu Suncadia Medicine Recent Developments
  31. 8.6 Zydus
  32. 8.6.1 Zydus Company Information
  33. 8.6.2 Zydus Business Overview
  34. 8.6.3 Zydus Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zydus Icosapent Ethyl Drugs Product Portfolio
  36. 8.6.5 Zydus Recent Developments
  37. 8.7 Woodward Pharma
  38. 8.7.1 Woodward Pharma Company Information
  39. 8.7.2 Woodward Pharma Business Overview
  40. 8.7.3 Woodward Pharma Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Woodward Pharma Icosapent Ethyl Drugs Product Portfolio
  42. 8.7.5 Woodward Pharma Recent Developments
  43. 8.8 Teva
  44. 8.8.1 Teva Company Information
  45. 8.8.2 Teva Business Overview
  46. 8.8.3 Teva Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Teva Icosapent Ethyl Drugs Product Portfolio
  48. 8.8.5 Teva Recent Developments
  49. 8.9 Sun Pharma
  50. 8.9.1 Sun Pharma Company Information
  51. 8.9.2 Sun Pharma Business Overview
  52. 8.9.3 Sun Pharma Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sun Pharma Icosapent Ethyl Drugs Product Portfolio
  54. 8.9.5 Sun Pharma Recent Developments
  55. 8.10 Strides Pharma
  56. 8.10.1 Strides Pharma Company Information
  57. 8.10.2 Strides Pharma Business Overview
  58. 8.10.3 Strides Pharma Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Strides Pharma Icosapent Ethyl Drugs Product Portfolio
  60. 8.10.5 Strides Pharma Recent Developments
  61. 8.11 PuraCap Pharmaceuticals
  62. 8.11.1 PuraCap Pharmaceuticals Company Information
  63. 8.11.2 PuraCap Pharmaceuticals Business Overview
  64. 8.11.3 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  66. 8.11.5 PuraCap Pharmaceuticals Recent Developments
  67. 8.12 Mankind Pharma
  68. 8.12.1 Mankind Pharma Company Information
  69. 8.12.2 Mankind Pharma Business Overview
  70. 8.12.3 Mankind Pharma Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Mankind Pharma Icosapent Ethyl Drugs Product Portfolio
  72. 8.12.5 Mankind Pharma Recent Developments
  73. 8.13 Hikma
  74. 8.13.1 Hikma Company Information
  75. 8.13.2 Hikma Business Overview
  76. 8.13.3 Hikma Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hikma Icosapent Ethyl Drugs Product Portfolio
  78. 8.13.5 Hikma Recent Developments
  79. 8.14 GLW Pharma
  80. 8.14.1 GLW Pharma Company Information
  81. 8.14.2 GLW Pharma Business Overview
  82. 8.14.3 GLW Pharma Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 GLW Pharma Icosapent Ethyl Drugs Product Portfolio
  84. 8.14.5 GLW Pharma Recent Developments
  85. 8.15 Dr. Reddy's Laboratories
  86. 8.15.1 Dr. Reddy's Laboratories Company Information
  87. 8.15.2 Dr. Reddy's Laboratories Business Overview
  88. 8.15.3 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product Portfolio
  90. 8.15.5 Dr. Reddy's Laboratories Recent Developments
  91. 8.16 Ascent Pharmaceuticals
  92. 8.16.1 Ascent Pharmaceuticals Company Information
  93. 8.16.2 Ascent Pharmaceuticals Business Overview
  94. 8.16.3 Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Ascent Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  96. 8.16.5 Ascent Pharmaceuticals Recent Developments
  97. 8.17 Apotex
  98. 8.17.1 Apotex Company Information
  99. 8.17.2 Apotex Business Overview
  100. 8.17.3 Apotex Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Apotex Icosapent Ethyl Drugs Product Portfolio
  102. 8.17.5 Apotex Recent Developments
  103. 8.18 Amneal Pharmaceuticals
  104. 8.18.1 Amneal Pharmaceuticals Company Information
  105. 8.18.2 Amneal Pharmaceuticals Business Overview
  106. 8.18.3 Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Amneal Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  108. 8.18.5 Amneal Pharmaceuticals Recent Developments
  109. 8.19 Amarin Pharmaceuticals
  110. 8.19.1 Amarin Pharmaceuticals Company Information
  111. 8.19.2 Amarin Pharmaceuticals Business Overview
  112. 8.19.3 Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Amarin Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  114. 8.19.5 Amarin Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Icosapent Ethyl Drugs Value Chain Analysis
  2. 9.1.1 Icosapent Ethyl Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Icosapent Ethyl Drugs Production Mode & Process
  6. 9.2 Icosapent Ethyl Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Icosapent Ethyl Drugs Distributors
  9. 9.2.3 Icosapent Ethyl Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst